Wellington Management Group
ORIC icon

Wellington Management Group’s Oric Pharmaceuticals ORIC Stock Holding History

Wellington Management Group’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.31M Buy
213,373
+27,274
+15% +$247K ﹤0.01% 1599
2026
Q1 		$2.36M Sell
186,099
-5,724
-3% -$65K ﹤0.01% 1522
2025
Q4 		$1.57M Buy
191,823
+41,229
+27% +$475K ﹤0.01% 1648
2025
Q3 		$1.81M Sell
150,594
-72,708
-33% -$765K ﹤0.01% 1657
2025
Q2 		$2.27M Buy
223,302
+45,085
+25% +$303K ﹤0.01% 1551
2025
Q1 		$994K Sell
178,217
-8,213
-4% -$71.8K ﹤0.01% 1711
2024
Q4 		$1.5M Buy
186,430
+12,042
+7% +$110K ﹤0.01% 1640
2024
Q3 		$1.79M Buy
174,388
+51,565
+42% +$510K ﹤0.01% 1569
2024
Q2 		$868K Buy
122,823
+10,850
+10% +$97.1K ﹤0.01% 1703
2024
Q1 		$1.54M Buy
111,973
+39,576
+55% +$470K ﹤0.01% 1582
2023
Q4 		$666K Buy
+72,397
New +$524K ﹤0.01% 1690

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group's ORIC Position: Q2 2026 in Review

Wellington Management Group increased its Oric Pharmaceuticals (ORIC) stake by 15% in Q2 2026, buying an estimated $247K and bringing the position to 213,373 shares worth $2.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1599.

Wellington Management Group first reported a position in ORIC in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.36M in Q1 2026. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Wellington Management Group held 213,373 shares of Oric Pharmaceuticals worth $2.31M as of Q2 2026.
  • Wellington Management Group bought 27,274 Oric Pharmaceuticals shares in Q2 2026, an estimated $247K.
  • Oric Pharmaceuticals made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1599 holding.
  • Wellington Management Group first reported a position in Oric Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Wellington Management Group's Oric Pharmaceuticals position peaked at $2.36M in Q1 2026.
  • 181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.